Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence
Viruses · 2024
DOI: 10.3390/v16030447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Laura Manuto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua, Italian Ministry of University and Research, University of Padova (Italy).
Abstract (Originalsprache)
During the COVID-19 pandemic, immunosuppressed patients showed prolonged SARS-CoV-2 infections, with several studies reporting the accumulation of mutations in the viral genome. The weakened immune system present in these individuals, along with the effect of antiviral therapies, are thought to create a favourable environment for intra-host viral evolution and have been linked to the emergence of new viral variants which strongly challenged containment measures and some therapeutic treatments. To assess whether impaired immunity could lead to the increased instability of viral genomes, longitudinal nasopharyngeal swabs were collected from eight immunocompromised patients and fourteen non-immunocompromised subjects, all undergoing SARS-CoV-2 infection. Intra-host viral evolution was compared between the two groups through deep sequencing, exploiting a probe-based enrichment method to minimise the possibility of artefactual mutations commonly generated in amplicon-based methods, which heavily rely on PCR amplification. Although, as expected, immunocompromised patients experienced significantly longer infections, the acquisition of novel intra-host viral mutations was similar between the two groups. Moreover, a thorough analysis of viral quasispecies showed that the variability of viral populations in the two groups is comparable not only at the consensus level, but also when considering low-frequency mutations. This study suggests that a compromised immune system alone does not affect SARS-CoV-2 within-host genomic variability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
- Department of Medicine, DIMED, University of Padova, 35128 Padova, Italy.
- Unit of Microbiology and Virology, University Hospital of Padova, 35128 Padova, Italy.
- Unit of Infectious Diseases, University Hospital of Padova, 35128 Padova, Italy.
ORCID-Profile: Marco Cola, Anna Maria Cattelan, Stefano Toppo, Enrico Lavezzo
Förderung
- University of Padua
- Italian Ministry of University and Research
- University of Padova (Italy)
Zitieren
APA
Manuto, L., Bado, M., Cola, M., Vanzo, E., Antonello, M., Mazzotti, G., Pacenti, M., Cordioli, G., Sasset, L., Cattelan, A. M., Toppo, S., & Lavezzo, E. (2024). Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence. Viruses. https://doi.org/10.3390/v16030447
Vancouver
Manuto L, Bado M, Cola M, Vanzo E, Antonello M, Mazzotti G, et al. Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence. Viruses. 2024. doi:10.3390/v16030447
BibTeX
@article{Manuto2024,
author = {Manuto, Laura and Bado, Martina and Cola, Marco and Vanzo, Elena and Antonello, Maria and Mazzotti, Giorgia and Pacenti, Monia and Cordioli, Giampaolo and Sasset, Lolita and Cattelan, Anna Maria and Toppo, Stefano and Lavezzo, Enrico},
title = {Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16030447}
}
EUVIMED